(VIANEWS) – OKEANIS ECO TANKER (OET.OL), CATANA GROUP (CATG.PA), X-FAB (XFAB.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OKEANIS ECO TANKER (OET.OL)
580.7% sales growth and 42.46% return on equity
Okeanis Eco Tankers Corp., a tanker company, engages in the ownership, chartering and operation of oil tanker vessels worldwide. The company also provides various shipping services, such as technical support, maintenance, and insurance consulting services. It operates a fleet of six modern scrubber-fitted Suezmax tankers and eight modern scrubber-fitted VLCC tankers. The company was incorporated in 2018 and is based in Piraeus, Greece.
Earnings Per Share
As for profitability, OKEANIS ECO TANKER has a trailing twelve months EPS of kr59.19.
PE Ratio
OKEANIS ECO TANKER has a trailing twelve months price to earnings ratio of 5.05. Meaning, the purchaser of the share is investing kr5.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.46%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 65.6% and 604%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 140.2%, now sitting on 411.81M for the twelve trailing months.
More news about OKEANIS ECO TANKER.
2. CATANA GROUP (CATG.PA)
37.9% sales growth and 30.39% return on equity
SA Catana Group manufactures and sells pleasure boats, sails, and motors in France and internationally. It also offers boat work, garage rentals, guarding, and berth services. The company markets its products under the CATANA, BALI, and CATSPACE brands. SA Catana Group was founded in 2001 and is headquartered in Canet-en-Roussillon, France.
Earnings Per Share
As for profitability, CATANA GROUP has a trailing twelve months EPS of €0.57.
PE Ratio
CATANA GROUP has a trailing twelve months price to earnings ratio of 12.93. Meaning, the purchaser of the share is investing €12.93 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.39%.
Volume
Today’s last reported volume for CATANA GROUP is 12057 which is 61.87% below its average volume of 31627.
Revenue Growth
Year-on-year quarterly revenue growth grew by 33.8%, now sitting on 172.53M for the twelve trailing months.
Moving Average
CATANA GROUP’s worth is way higher than its 50-day moving average of €6.58 and higher than its 200-day moving average of €6.92.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 1, 2023, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 2.77%.
More news about CATANA GROUP.
3. X-FAB (XFAB.PA)
23.3% sales growth and 13.03% return on equity
X-FAB Silicon Foundries SE operates as an analog/mixed-signal semiconductor technology foundry. The company manufactures silicon wafers for automotive, industrial, consumer, medical, and mobile communications, and other applications; and analog/mixed-signal integrated circuits, sensors, and micro-electro-mechanical systems. It also provides manufacturing and design support services for customers that design analog/mixed-signal integrated circuits and other semiconductor devices, as well as engineering and prototyping, outsourcing, technical, and design support services. The company serves integrated device manufacturers, original equipment manufacturers, and fabless semiconductor companies. It operates in Belgium, Germany, the United Kingdom, Austria, France, Switzerland, Denmark, Sweden, Finland, Netherlands, Ireland, Singapore, China, Japan, Thailand, Malaysia, Korea, Taiwan, Hong Kong, New Zealand, the United States, and internationally. The company was founded in 1992 and is based in Tessenderlo, Belgium.
Earnings Per Share
As for profitability, X-FAB has a trailing twelve months EPS of €0.74.
PE Ratio
X-FAB has a trailing twelve months price to earnings ratio of 14.05. Meaning, the purchaser of the share is investing €14.05 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.03%.
Volume
Today’s last reported volume for X-FAB is 25023 which is 82.03% below its average volume of 139276.
Moving Average
X-FAB’s value is higher than its 50-day moving average of €9.89 and way above its 200-day moving average of €9.11.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 807.21M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
X-FAB’s EBITDA is 17.73.
More news about X-FAB.
4. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 33.05. Meaning, the purchaser of the share is investing kr33.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr39.00 at 22:20 EST, way under its 52-week high of kr43.90 and way higher than its 52-week low of kr31.00.
Volume
Today’s last reported volume for NAVAMEDIC is 14607 which is 66.19% below its average volume of 43204.
More news about NAVAMEDIC.
5. MULTICONSULT (MULTI.OL)
10% sales growth and 34.44% return on equity
Multiconsult ASA provides engineering design, consultancy, and architecture services in Norway and internationally. The company offers multidisciplinary consultancy, design, planning, project supervision and management, geotechnical site survey, verification and control, analysis and due diligence, construction management, geological investigations, environmental services and HSE, river basin management, hydrometry, and hydrological field work services. It serves buildings and properties, cities and society, industry, oil and gas, renewable energy, rail and transportation, and water and environment sectors. Multiconsult ASA was founded in 1908 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MULTICONSULT has a trailing twelve months EPS of kr11.58.
PE Ratio
MULTICONSULT has a trailing twelve months price to earnings ratio of 11.36. Meaning, the purchaser of the share is investing kr11.36 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.44%.
Sales Growth
MULTICONSULT’s sales growth for the next quarter is 10%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 14, 2023, the estimated forward annual dividend rate is 9 and the estimated forward annual dividend yield is 6.72%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10%, now sitting on 4.47B for the twelve trailing months.
Volume
Today’s last reported volume for MULTICONSULT is 2144 which is 55.76% below its average volume of 4847.
More news about MULTICONSULT.
6. SPBK1 RINGERIKE (RING.OL)
9.7% sales growth and 10.68% return on equity
SpareBank 1 Ringerike Hadeland provides various banking products and services to private and corporate customers in Norway. The company offers saving, current, deposit, and currency accounts; vehicle, house and travel, and animal insurance products, as well as life, child, disability, critical illness, accident, health, and business and personal insurance products; mobile and online banking services; and debit and credit cards. It also provides mortgages; car, boat, and other vehicles; consumer and other loans; and bank guarantees, corporate and construction loans, liquidity loans with a government guarantee, and operating credit for agriculture, as well as factoring, leasing, and overdraft services. In addition, the company offers services for buying and selling property; accounting services; pension products; and savings and investment products. The company was founded in 1833 and is based in Hønefoss, Norway.
Earnings Per Share
As for profitability, SPBK1 RINGERIKE has a trailing twelve months EPS of kr27.15.
PE Ratio
SPBK1 RINGERIKE has a trailing twelve months price to earnings ratio of 11.05. Meaning, the purchaser of the share is investing kr11.05 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.68%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 46.7% and 26.8%, respectively.
Moving Average
SPBK1 RINGERIKE’s worth is under its 50-day moving average of kr307.72 and below its 200-day moving average of kr321.61.
More news about SPBK1 RINGERIKE.
7. PERNOD RICARD (RI.PA)
7.9% sales growth and 13.85% return on equity
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. Pernod Ricard SA was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.31.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 20.92. Meaning, the purchaser of the share is investing €20.92 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.85%.
More news about PERNOD RICARD.
